Entry regulations affecting professional services such as pharmacies are common practice in many European countries. We assess the impact of entry regulations on profits estimating a structural model of entry using the information provided by a policy experiment. We use the case of different regional policies governing the opening of new pharmacies in Spain to show that structural models of entry ought to be estimated with data from policy experiments to pin down how entry regulations change payoffs functions of the incumbents. Contrary to the public interest rationales, regulations are not boosting only small town pharmacies payoffs nor increasing all pharmacies payoffs alike. The gains from regulations are very unevenly distributed,sugges...
We present a model of the strategic interaction among authorities regulating pharmaceutical prices i...
This paper provides new empirical evidence on entry and competition in the Portuguese market of reta...
Most countries regulate pharmaceutical prices, either directly or indirectly, on the assumption that...
Entry regulations affecting professional services such as pharmacies are common practice in many Eur...
The health care professions in Europe have been subject to substantial entry and conduct regulation....
The health care professions in Europe have been subject to substantial entry and conduct regulation....
Health care professions have been subject to substantial entry and conduct regulation. Most notably,...
Health care professions have been subject to substantial entry and conduct regula-tion. Most notably...
We examine a deregulation of German pharmacists to assess its effects on retail and labor markets. F...
In this paper, we focus on regulatory restrictions on Community Pharmacies and whether these have an...
The regulation of pharmacists in belgium and the netherlands is analysed in order to test the rent-s...
Essay 1: Entry and Regulation - Evidence from Health Care ProfessionsAbstract: In many countries pha...
Broadly speaking, pharmaceutical policy in Spain has been unable to control either the price or the ...
Contending that European policy makers, in their efforts to protect patient's health, have enacted a...
The aim of this paper is to analyse empirically entry decisions by generic firms into markets with t...
We present a model of the strategic interaction among authorities regulating pharmaceutical prices i...
This paper provides new empirical evidence on entry and competition in the Portuguese market of reta...
Most countries regulate pharmaceutical prices, either directly or indirectly, on the assumption that...
Entry regulations affecting professional services such as pharmacies are common practice in many Eur...
The health care professions in Europe have been subject to substantial entry and conduct regulation....
The health care professions in Europe have been subject to substantial entry and conduct regulation....
Health care professions have been subject to substantial entry and conduct regulation. Most notably,...
Health care professions have been subject to substantial entry and conduct regula-tion. Most notably...
We examine a deregulation of German pharmacists to assess its effects on retail and labor markets. F...
In this paper, we focus on regulatory restrictions on Community Pharmacies and whether these have an...
The regulation of pharmacists in belgium and the netherlands is analysed in order to test the rent-s...
Essay 1: Entry and Regulation - Evidence from Health Care ProfessionsAbstract: In many countries pha...
Broadly speaking, pharmaceutical policy in Spain has been unable to control either the price or the ...
Contending that European policy makers, in their efforts to protect patient's health, have enacted a...
The aim of this paper is to analyse empirically entry decisions by generic firms into markets with t...
We present a model of the strategic interaction among authorities regulating pharmaceutical prices i...
This paper provides new empirical evidence on entry and competition in the Portuguese market of reta...
Most countries regulate pharmaceutical prices, either directly or indirectly, on the assumption that...